Organization Profile

Related Organization(s)

You just read:

New Safety and Long-Term Efficacy Data from Baricitinib Clinical Trials in Patients with Moderate-to-Severe Rheumatoid Arthritis Presented at EULAR 2017

News provided by

Eli Lilly and Company

Jun 16, 2017, 04:15 ET